Word Finding Difficulty: Labs and Next Steps for Women

What Word Finding Difficulty Actually Is

Word finding difficulty means you know what you want to say but the right word will not come. The name stalls on your tongue. You substitute "the thing in the kitchen" for "colander." Neurologists call this anomia. Psychologists call the milder form a tip-of-the-tongue (TOT) state.

This is not the same as forgetting the concept entirely. The retrieval pathway between the idea and its label is disrupted. Functional MRI studies show this disruption involves the left inferior frontal gyrus and the posterior temporal cortex, regions that are sensitive to estrogen fluctuation.

Word finding difficulty exists on a spectrum. Occasional TOT states are normal across the human lifespan. Frequent or worsening episodes that interfere with conversations, work presentations, or daily life deserve a clinical workup.

Why Women Are Disproportionately Affected

Women are not imagining this. The female brain operates differently across the reproductive lifespan because of fluctuating estrogen, progesterone, and other neuroactive steroids. Estrogen receptors are densely expressed in the hippocampus and prefrontal cortex, two regions that support verbal memory and lexical retrieval.

Estrogen and Verbal Memory

Estrogen acts on the cholinergic system, which governs attention and verbal fluency. When estrogen drops, acetylcholine signaling in the hippocampus decreases. The result can be slower lexical access. A 2021 analysis in Menopause found that women in the menopausal transition reported verbal memory complaints at rates significantly higher than same-aged men, a gap that narrowed in postmenopause once estrogen had restabilized at its lower baseline.

The Menstrual Cycle Connection

Even in your reproductive years, verbal fluency shifts across your cycle. Research from the Study of Women's Health Across the Nation (SWAN) cognitive substudy documented that verbal episodic memory scores fluctuated measurably across menstrual cycle phases, with the luteal phase (after ovulation) associated with slight performance dips for some women. If your word finding gets worse in the week before your period, that pattern is worth tracking and reporting.

Perimenopause: The Peak Complaint Window

Perimenopause is when most women first report word finding as a problem worth mentioning to a clinician. The menopausal transition can last four to ten years and is characterized by erratic estrogen swings rather than a smooth decline. The SWAN study followed over 3,000 women longitudinally and found that processing speed and verbal memory declined during the menopausal transition, then partially recovered in postmenopause. That partial recovery is reassuring but not guaranteed, which is why addressing modifiable factors early matters.

Postpartum and Lactation

Postpartum word finding difficulty is so common it has a colloquial name ("baby brain") and genuine biological grounding. Estrogen and progesterone drop precipitously after delivery. Sleep deprivation compounds the cognitive load. Prolactin, which rises during lactation, may suppress hypothalamic GnRH and downstream estrogen production, contributing to a low-estrogen state that can persist throughout breastfeeding. Most postpartum cognitive symptoms resolve within six to twelve months, but postpartum thyroiditis affects up to 10% of women in the year after delivery and is a correctable cause of brain fog and word finding difficulty that should be screened.

Common Causes Organized by Likelihood

Not every cause is hormonal. A systematic approach helps you and your clinician work through the differential efficiently.

Hormonal and Endocrine Causes

Thyroid dysfunction is the single most important diagnosis not to miss. Both hypothyroidism and hyperthyroidism cause cognitive symptoms, including word finding difficulty. Hypothyroidism slows all neural processing. Hyperthyroidism creates anxious, distractible cognition that fractures retrieval. The American Thyroid Association estimates that up to 20 million Americans have some form of thyroid disease, and women are five to eight times more likely than men to be affected. TSH is the first-line test.

Perimenopause and menopause. As described above, the transition is a high-risk window. The Menopause Society 2023 position statement states: "Cognitive symptoms, including difficulty with verbal memory and attention, are among the most commonly reported complaints during the menopausal transition and warrant clinical attention rather than dismissal."

Elevated cortisol / chronic stress. Cortisol excess (from chronic psychosocial stress or, less commonly, Cushing syndrome) physically reduces hippocampal volume. A 2018 study in Nature Communications linked higher salivary cortisol to worse verbal memory retrieval in midlife women.

Low testosterone in women. Testosterone is often overlooked as a neuroactive hormone in women. Female testosterone levels decline from the mid-20s onward. Some data suggest low testosterone correlates with verbal fluency decline, though the evidence in women remains limited and direct trials are sparse.

Nutritional and Metabolic Causes

Vitamin B12 deficiency impairs myelin synthesis, slowing neural conduction. Strict plant-based diets, metformin use, proton pump inhibitor use, and autoimmune gastritis all increase risk. Serum B12 below 200 pg/mL is associated with neurological symptoms including cognitive slowing.

Iron deficiency (with or without anemia). Ferritin below 30 ng/mL may impair dopamine synthesis, which affects prefrontal executive function and lexical retrieval speed. Women of reproductive age lose iron monthly through menstruation. Check ferritin, not just hemoglobin.

Insulin resistance and elevated blood glucose. The brain is an insulin-sensitive organ. Glucose dysregulation, even pre-diabetes, is associated with slower processing speed. The ARIC Neurocognitive Study found that midlife hyperglycemia predicted steeper cognitive decline over 20 years.

Vitamin D insufficiency. Vitamin D receptors are expressed in the brain and involved in neuroprotection. Low 25-hydroxyvitamin D (<30 ng/mL) has been associated with cognitive complaints in observational studies, though causality is not established.

Sleep, Stress, and Mental Health

Sleep is when the glymphatic system clears metabolic waste from the brain. The glymphatic system is two to three times more active during sleep, and even one night of poor sleep measurably slows lexical retrieval the next morning. Women are more likely than men to have insomnia, restless legs syndrome, and sleep-disordered breathing that worsens in perimenopause.

Depression and anxiety also directly disrupt retrieval networks. Women are diagnosed with depression at roughly twice the rate of men across the lifespan, and subjective cognitive complaints, including word finding difficulty, are among the most frequently endorsed symptoms of major depressive disorder.

Medications That Affect Word Retrieval

Several commonly prescribed medications can cause word finding difficulty as a side effect.

• Topiramate (used for migraines, seizures, and sometimes weight): well-documented adverse effect on verbal fluency, sometimes called "Topamax fog."
• Benzodiazepines and sleep aids: sedative-hypnotics impair encoding and retrieval.
• Beta-blockers: may slow processing speed in some women.
• Anticholinergic medications: diphenhydramine (Benadryl), certain bladder medications (oxybutynin), and some antidepressants (tricyclics) block the same acetylcholine system that estrogen supports.
• Hormonal contraceptives: some women report cognitive changes on progestin-dominant combined pills, though trial data are mixed and effects appear to depend on the specific progestin.

Always bring a complete medication list, including over-the-counter and herbal supplements, to your appointment.

Neurological Causes (Less Common, But Must Be Considered)

Word finding difficulty is a feature of several neurological conditions. These are statistically less common than hormonal and metabolic causes, but they require evaluation when symptoms are progressive, sudden in onset, or accompanied by other neurological signs.

Multiple sclerosis (MS): Women are about three times more likely than men to develop MS. Cognitive symptoms including verbal processing speed are among the most common MS-related complaints. Approximately 50-65% of people with MS experience some degree of cognitive impairment.

Migraine with aura: Migraineurs can experience word finding difficulty during the aura or prodrome phase and sometimes interictally.

Mild cognitive impairment (MCI) and early dementia: Women account for nearly two-thirds of Alzheimer's disease cases in the United States. The Alzheimer's Association 2024 Facts and Figures report estimates that 6.9 million Americans age 65 and older are living with Alzheimer's, and women bear a disproportionate burden. Progressive, worsening anomia that does not fluctuate with hormonal cycles or sleep quality warrants formal neuropsychological evaluation.

Stroke or TIA: Sudden-onset word finding difficulty, particularly when accompanied by unilateral weakness, facial droop, vision changes, or severe headache, is a medical emergency. Call 911. Do not wait for a telehealth appointment.

The Lab Workup: What to Ask For

Below is a tiered framework for the word finding difficulty workup in women, organized by clinical priority. Your clinician may modify this based on your specific history.

Tier 1: Order for Every Woman

| Lab | Why It Matters | Target Range | |---|---|---| | TSH | Rules out thyroid dysfunction (most common missed cause) | 0.5-4.5 mIU/L (optimize to 1-2.5 if symptomatic) | | Free T4 | Confirms conversion if TSH is abnormal | Lab-specific | | CBC | Screens for anemia | Hemoglobin >12 g/dL | | Ferritin | Iron stores; hemoglobin can be normal while ferritin is low | >50 ng/mL for cognitive symptoms | | Fasting glucose + HbA1c | Metabolic status | FG <100 mg/dL; HbA1c <5.7% | | Vitamin B12 | Deficiency causes neurological symptoms | >300 pg/mL to be safe | | 25-OH Vitamin D | Neuroprotection; deficiency common | 40-60 ng/mL | | CMP (comprehensive metabolic panel) | Liver, kidney, electrolytes | Lab-specific |

Tier 2: Add Based on Life Stage and History

| Lab | When to Add | |---|---| | FSH + estradiol | Perimenopause suspected (age 40+, cycle changes, hot flashes) | | Morning cortisol | Chronic stress, fatigue, weight changes | | Free testosterone + SHBG | Low libido alongside cognitive symptoms | | Thyroid antibodies (TPO, anti-Tg) | Thyroid history, postpartum, family history of autoimmune disease | | Fasting lipids | Cardiovascular risk assessment in midlife | | Homocysteine | Elevated B12/folate concern, cardiovascular risk |

Tier 3: Specialist-Directed

• Neuropsychological testing (if progressive symptoms or age >55)
• MRI brain (if neurological signs, progressive course, or red flags)
• Sleep study / polysomnography (if snoring, unrefreshing sleep, or suspected sleep apnea)
• Referral to neurology or cognitive neurology

Interpreting Your Results: What "Normal" Labs Don't Always Mean

A TSH of 3.8 mIU/L falls within many lab reference ranges but may be suboptimal for a symptomatic woman. Many thyroid-informed clinicians target TSH between 1.0 and 2.5 mIU/L for women with hypothyroid symptoms. This is a clinical judgment call, not a universal guideline.

Similarly, a ferritin of 18 ng/mL is technically "in range" by some lab standards but is associated with cognitive symptoms in menstruating women. Ask for your actual number, not just whether it is flagged as abnormal.

Estradiol interpretation is context-dependent. A level of 40 pg/mL in a 35-year-old in the mid-follicular phase is very different from the same level in a 48-year-old with cycle irregularity. What matters is the clinical picture, not the number in isolation.

Who This Is Right For and Who Needs a Different Path

Women Who Fit the Typical Presentation

You are in the most straightforward diagnostic category if your word finding difficulty:

• Started or worsened in perimenopause or postpartum
• Fluctuates with your cycle or sleep quality
• Accompanies other symptoms such as fatigue, heat intolerance, low mood, or heavy periods
• Has no associated neurological symptoms

For this group, the Tier 1 lab panel plus a hormonal assessment is the appropriate starting point. Most find a correctable cause.

Women Who Need More Urgent or Specialized Evaluation

Seek evaluation within days, not weeks, if:

• Symptoms came on suddenly rather than gradually
• You notice other people commenting on your speech before you do
• Word finding difficulty is accompanied by confusion, personality change, or difficulty understanding others
• You are under 40 with no identifiable hormonal or metabolic cause
• Symptoms are progressively worsening regardless of sleep, stress, or cycle phase

A neurologist or cognitive neurologist, not just primary care or telehealth, is the right provider for this group.

Women with PCOS

PCOS is associated with insulin resistance, elevated androgens, and disordered sleep (higher rates of sleep apnea). All three factors independently affect cognitive function. If you have PCOS and word finding difficulty, insulin resistance is a particularly high-priority target. A fasting insulin level in addition to glucose and HbA1c gives a fuller picture of metabolic status.

Women with Autoimmune Conditions

Autoimmune thyroiditis (Hashimoto's), lupus, Sjögren's syndrome, and celiac disease are all more common in women and can all produce cognitive symptoms. If you have any autoimmune diagnosis or a strong family history, expand thyroid testing to include TPO antibodies and discuss a celiac panel (tissue transglutaminase IgA) with your clinician.

Treatment Directions Based on Root Cause

Treatment targets the underlying cause. There is no single pill for word finding difficulty.

Treating Thyroid Dysfunction

Levothyroxine is the standard treatment for hypothyroidism. Cognitive symptoms often improve within six to twelve weeks of reaching a therapeutic TSH. Some women report better cognitive outcomes on combination T4/T3 therapy (levothyroxine plus liothyronine), though randomized trial evidence from the NEJM combination therapy trial showed mixed results and guidelines do not universally endorse this approach.

Hormone Therapy in Perimenopause

Menopausal hormone therapy (MHT) may help verbal memory symptoms in perimenopausal women who start treatment close to menopause. The "timing hypothesis" holds that estrogen is neuroprotective when started during the transition but may not benefit (and could harm) women who start a decade or more after menopause. The Menopause Society supports individualized MHT discussions for symptomatic women under 60 or within 10 years of menopause. MHT is not approved as a dementia prevention strategy.

Correcting Nutritional Deficiencies

B12 deficiency: oral cyanocobalamin 1,000 to 2,000 mcg daily or intramuscular injections if absorption is impaired (pernicious anemia). Iron deficiency: oral ferrous sulfate 325 mg every other day is as effective as daily dosing with fewer gastrointestinal side effects per a 2017 trial in Blood, and causes less GI distress. Vitamin D deficiency: 2,000 IU daily is a reasonable starting dose; recheck in three months.

Sleep and Stress

Cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment for chronic insomnia, outperforming sleep medications in head-to-head trials and without the cognitive side effects of sedatives. If sleep apnea is found, CPAP treatment has been shown to improve verbal processing speed within three months of consistent use.

Reviewing Medications

If topiramate, an anticholinergic, or a sedative-hypnotic is on your list and your cognitive symptoms started or worsened after initiation, bring this to your prescriber. Alternatives often exist.

When to Seek Specialty Referral

A telehealth initial evaluation is appropriate for most women with gradual-onset word finding difficulty and no neurological red flags. Specialty referral is indicated when:

• Labs are normal and symptoms persist beyond three months
• Neuropsychological testing is needed to characterize the deficit
• Neurological symptoms accompany the word finding difficulty
• MRI or further imaging is warranted

Ask your telehealth clinician to coordinate a warm referral rather than leaving you to manage the specialist system alone.

Pregnancy and Postpartum: Special Considerations

Word finding difficulty during pregnancy is extremely common and is not a marker of future cognitive decline. Up to 80% of pregnant women report subjective cognitive changes, a phenomenon sometimes called "pregnancy brain" or "momnesia." Objective neuropsychological testing shows more modest but real changes in verbal memory and processing speed, particularly in the third trimester.

What to screen for during pregnancy and postpartum:

• TSH in the first trimester (ACOG recommends screening in women with symptoms or risk factors; ACOG Practice Bulletin on thyroid disease in pregnancy recommends prompt treatment of overt hypothyroidism)
• Ferritin: iron deficiency anemia affects up to 30% of pregnant women and is a correctable cause of cognitive symptoms
• Screening for postpartum depression at the six-week and six-month visits, since depression is itself a driver of word finding difficulty
• Postpartum thyroiditis screening with TSH at three and six months postpartum if symptomatic

Medication safety during pregnancy and lactation:

If word finding difficulty prompts a new medication, the safety profile changes substantially during pregnancy and breastfeeding. Levothyroxine is safe and essential during pregnancy if hypothyroidism is confirmed. Oral iron and vitamin B12 are safe during pregnancy and lactation. Vitamin D at standard replacement doses (up to 4,000 IU/day) is considered safe in pregnancy. Topiramate is FDA Pregnancy Category D (risk of fetal harm including oral clefts) and should not be initiated in pregnancy; women of reproductive age taking topiramate should use reliable contraception. Benzodiazepines carry risks in pregnancy and pass into breast milk; avoid initiating during pregnancy or lactation.

Tracking Your Symptoms Before Your Appointment

Bring a one-week symptom log to your appointment. Note:

1. Time of day when word finding is worst
2. Sleep quality the night before
3. Where you are in your menstrual cycle (day 1 = first day of bleeding)
4. Recent stress events
5. Any new medications or supplements started in the past six months

This log takes fifteen minutes to create and dramatically improves the quality of the clinical conversation. Clinicians can identify patterns (luteal phase worsening, sleep-linked episodes) that a single office visit cannot capture.